Medicare AdvantageCoverageMedium impact
High-Intensity Focused Ultrasound (HIFU) in the Treatment of Malignant Prostate Tissue for Medicare Advantage Members (Effective July 1, 2026)
Independence Blue Cross·Urology·News & Announcements
Effective date
Jul 1, 2026
We identified it
Aug 4, 2026
Summary
This policy establishes coverage guidelines for High-Intensity Focused Ultrasound (HIFU) as a treatment for malignant prostate tissue in Medicare Advantage members, effective July 1, 2026. The billing team must implement prior authorization requirements and ensure claims are processed according to the new coverage criteria for this procedure.
Action Required
By June 15, 2026: Billing team must review the complete HIFU policy at https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=08&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#medicare-advantage-high-intensity-focused-ultrasound-hifu-in to extract specific CPT/HCPCS codes and prior authorization requirements. Update billing software to require prior authorization for HIFU prostate procedures on all Medicare Advantage claims submitted on or after July 1, 2026. Add HIFU authorization workflow to encounter templates used by urology providers. Notify urology department of new authorization requirements before the effective date. Claims submitted without required prior authorization will be denied by Medicare Advantage plans.